Unusual 11 Mid-Day Movers 03/20: (GALE) (GMAN) (ACAD) Higher; (TRGT) (DHT) (OSG) Lower
Tweet Send to a Friend
Get Alerts TRGT Hot Sheet
Trade TRGT Now!
Targacept, Inc. (Nasdaq: TRGT) 27.7% LOWER; AstraZeneca (NYSE: AZN) and Targacept announced top-line results from the remaining Phase 3 studies investigating efficacy, tolerability and safety of TC-5214 as an adjunct therapy to an antidepressant in patients with major depressive disorder who did not respond adequately to initial antidepressant treatment. RENAISSANCE 4 and RENAISSANCE 5, both efficacy and tolerability studies, did not meet the primary endpoint of change on the Montgomery-Asberg Depression Rating Scale (MADRS) total score after eight weeks of adjunct treatment with TC-5214 as compared to placebo.
DHT Holdings (NYSE: DHT) 26.7% LOWER; registered to sell 51.785 million shares of common stock and 258,929 shares of Series A Participating Preferred Stock.
Galena Biopharma (Nasdaq: GALE) 23.9% HIGHER; announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent covering the use of its product candidate, NeuVax, a HER2/neu peptide vaccine, for inducing immunity to breast cancer recurrence in patients having low-to-intermediate IHC ratings of 1+ or 2+ and a FISH rating of less than about 2.0. These patients represent a significant unmet medical need, with as much as 50 percent to 75 percent of breast cancer patients who do not qualify for Herceptin therapy.
Gordmans Stores (Nasdaq: GMAN) 23.1% HIGHER; reported Q4 EPS of $0.53, 3 cents better than the analyst estimate of $0.50. Revenue for the quarter came in at $185.1 million versus the consensus estimate of $186.11 million. Sees Q1 2012 EPS of $0.40 to $0.41, versus the consensus of $0.40. Sees Q1 2012 revenue of $132 million to $133 million, versus the consensus of $128.9 million. Sees FY2012 EPS of $1.46-$1.51, versus the consensus of $1.48. Sees FY2012 revenue of $629 million to $634 million, versus the consensus of $622.6 million.
ACADIA Pharma (Nasdaq: ACAD) 16.1% HIGHER; breaking above the $1.90 level and the stock's 200-day SMA. Volume spiked notably as the price pushed over $2.
Overseas Shipholding (NYSE: OSG) 12.4% LOWER; trading lower with most of the dry bulk shipping sector.
Inteliquent (Nasdaq: IQNT), 11.5% HIGHER; announced that the International Business Times has ranked Inteliquent #228 on the 2011 IBT1000 list; and #6 among telecom service provides worldwide. The IBT1000 celebrates companies that have outperformed others in the global marketplace.
Mattersight Corp (Nasdaq: MATR) 11.1% HIGHER; Craig-Hallum initiated coverage on MatterSight with a Buy.
Ixia (Nasdaq: XXIA) 10.8% LOWER; announced that Victor Alston has been appointed as Ixia's Chief Operating Officer and will stand for election to the Board of Directors at the Company's annual meeting of shareholders scheduled to be held on May 10, 2012. In addition, the Company announced that Atul Bhatnagar, the Company's President and CEO, will be leaving the Company effective as of the date of the annual meeting and will not stand for reelection to the Board. The stock was downgraded at Wunderlich earlier.
Delcath Systems, Inc. (Nasdaq: DCTH) 10.7% HIGHER; has received the first commercial order for the Company's Hepatic CHEMOSAT Delivery System from the European Institute of Oncology (Instituto Europeo di Oncologia – IEO) –a premier cancer treatment and research center in Europe. Delcath previously announced an initial launch and training agreement with the IEO on November 21, 2011.
Endocyte (Nasdaq: ECYT) 10.6% HIGHER; after testing below the $5 level yesterday, shares have popped higher Tuesday indicating a possible support at the $5 plateau.
Dole (NYSE: DOLE) 8.6% LOWER; J.P. Morgan downgraded Dole from Overweight to Neutral with a price target of $12.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
DHT Holdings (NYSE: DHT) 26.7% LOWER; registered to sell 51.785 million shares of common stock and 258,929 shares of Series A Participating Preferred Stock.
Galena Biopharma (Nasdaq: GALE) 23.9% HIGHER; announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent covering the use of its product candidate, NeuVax, a HER2/neu peptide vaccine, for inducing immunity to breast cancer recurrence in patients having low-to-intermediate IHC ratings of 1+ or 2+ and a FISH rating of less than about 2.0. These patients represent a significant unmet medical need, with as much as 50 percent to 75 percent of breast cancer patients who do not qualify for Herceptin therapy.
Gordmans Stores (Nasdaq: GMAN) 23.1% HIGHER; reported Q4 EPS of $0.53, 3 cents better than the analyst estimate of $0.50. Revenue for the quarter came in at $185.1 million versus the consensus estimate of $186.11 million. Sees Q1 2012 EPS of $0.40 to $0.41, versus the consensus of $0.40. Sees Q1 2012 revenue of $132 million to $133 million, versus the consensus of $128.9 million. Sees FY2012 EPS of $1.46-$1.51, versus the consensus of $1.48. Sees FY2012 revenue of $629 million to $634 million, versus the consensus of $622.6 million.
ACADIA Pharma (Nasdaq: ACAD) 16.1% HIGHER; breaking above the $1.90 level and the stock's 200-day SMA. Volume spiked notably as the price pushed over $2.
Overseas Shipholding (NYSE: OSG) 12.4% LOWER; trading lower with most of the dry bulk shipping sector.
Inteliquent (Nasdaq: IQNT), 11.5% HIGHER; announced that the International Business Times has ranked Inteliquent #228 on the 2011 IBT1000 list; and #6 among telecom service provides worldwide. The IBT1000 celebrates companies that have outperformed others in the global marketplace.
Mattersight Corp (Nasdaq: MATR) 11.1% HIGHER; Craig-Hallum initiated coverage on MatterSight with a Buy.
Ixia (Nasdaq: XXIA) 10.8% LOWER; announced that Victor Alston has been appointed as Ixia's Chief Operating Officer and will stand for election to the Board of Directors at the Company's annual meeting of shareholders scheduled to be held on May 10, 2012. In addition, the Company announced that Atul Bhatnagar, the Company's President and CEO, will be leaving the Company effective as of the date of the annual meeting and will not stand for reelection to the Board. The stock was downgraded at Wunderlich earlier.
Delcath Systems, Inc. (Nasdaq: DCTH) 10.7% HIGHER; has received the first commercial order for the Company's Hepatic CHEMOSAT Delivery System from the European Institute of Oncology (Instituto Europeo di Oncologia – IEO) –a premier cancer treatment and research center in Europe. Delcath previously announced an initial launch and training agreement with the IEO on November 21, 2011.
Endocyte (Nasdaq: ECYT) 10.6% HIGHER; after testing below the $5 level yesterday, shares have popped higher Tuesday indicating a possible support at the $5 plateau.
Dole (NYSE: DOLE) 8.6% LOWER; J.P. Morgan downgraded Dole from Overweight to Neutral with a price target of $12.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- Market Wrap: Bernanke Baffles Markets; Tesla Off the Hook; H-P Stuns Street
- 50-Day SMA Crossers 05/20: (ELN) (ACI) (AAPL) Above; (MRK) (TLAB) (CLSN) Below
Create E-mail Alert Related Categories
Special ReportsRelated Entities
JPMorgan, Unusual 11 Mid-Day Movers
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
